During the past decade, The Parkinson's Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 7 clinical trials were completed, i.e. on average, 233.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Parkinson's Institute" #1 sponsor was "Impax Laboratories, LLC" with 3 trials, followed by "Newron Pharmaceuticals SPA" with 3 trials sponsored, "The Parkinson's Institute" with 3 trials sponsored, "Chelsea Therapeutics" with 2 trials sponsored and "The Parkinson Study Group" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Parkinson's Institute" #1 collaborator was "H. Lundbeck A/S" with 2 trials as a collaborator, "Michael J. Fox Foundation for Parkinson's Research" with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "Bausch Health Americas, Inc." with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "The Parkinson's Institute" are "Parkinson's Disease" (14 trials), "Parkinson Disease" (4 trials), "Dopamine Beta Hydroxylase Deficiency" (2 trials), "Idiopathic Parkinson's Disease" (2 trials) and "Essential Tremor" (1 trials). Many other conditions were trialed in "The Parkinson's Institute" in a lesser frequency.

Most popular intervention types in "The Parkinson's Institute" are "Drug" (19 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Droxidopa" (2 trials), "2 mg perampanel" (1 trials), "4 mg perampanel" (1 trials) and "AFQ056 with L-dopa" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Parkinson's Institute" are 25 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The Parkinson's Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in The Parkinson's Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Parkinson's Institute, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".